AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
The FDA Opened the Door to Compounding
WeGoV is difficult to get and you have a patient who struggles with their weight. You believe in your professional opinion on the status care that this person is a candidate, what do you do and what two other medspots do? How have we gotten into this kind of loop where these compounding pharmacies are doing anything illegal or wrong? The rules are set up as they are, but how do we get here and what are your thoughts on the compounding issue? Sure. So I think again, the FDA opened the door to the compounding of some aglitide by calling it a short suppression. And it truly was. They initially opened the door. And it sounds like it